Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Summary

GlobalData’s new report, “Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market. The report provides market landscape, competitive landscape and market trends information on the implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Cardiac Resynchronisation Therapy - Defibrillators, Dual Chamber Implantable Cardioverter Defibrillators and Single Chamber Implantable Cardioverter Defibrillators.
- Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2010.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within the implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Medtronic, Boston Scientific, St. Jude Medical, BIOTRONIK and Sorin Group.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next big thing in the implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators market and the factors shaping it.

1 Table of Contents
1 Table of Contents 1
1.1 List of Tables 5
1.2 List of Figures 7
2 Executive Summary 8
2.1 The Global Implantable Cardioverter Defibrillators (ICD) and Cardiac Resynchronization Therapy-Defibrillators (CRT-D) Market is Forecast to Grow at a Rate of 5% Over the Period 2010–2017 8
2.2 Medtronic Dominates the Global ICD and CRT-D Market with a Share of More Than 40% 9
2.3 Increasing Patient Pool and Better Adoption Rates of ICD and CRT-D for Treatment of Cardiac Arrhythmias and Heart Failures to Drive Market Growth 9
2.4 The US is the Largest Market for ICD and CRT-D Devices Contributing about 56% of the Global Revenue in 2010 10
3 Introduction 11
3.1 GlobalData Report Guidance 11
4 Disease Overview - Arrhythmia 12
4.1 Types of Arrhythmia 12
4.2 Symptoms 13
5 Device Overview 14
5.1 Implantable Cardioverter Defibrillator (ICD) 14
5.1.1 Dual Chamber Implantable Cardioverter Defibrillator 14
5.1.2 Single Chamber Implantable Cardioverter Defibrillator 14
5.2 Cardio Resynchronization Therapy Defibrillators 14
6 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Market Characterization 15
6.1 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators Market, Global, Revenue ($bn), Historic, 2003-2010 15
6.2 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators Market, Global, Revenue ($bn), Forecast, 2010-2017 16
6.3 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators, Key Technology Trends 17
6.3.1 Percutaneous Implantable ICDs 17
6.3.2 Subcutaneous ICDs 17
6.3.3 Automatic Diagnosis 17
6.4 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators, Market Dynamics 17
6.4.1 Market Drivers 17
6.4.2 Market Restraints 22
7 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, by Country, Revenue, 2003 - 2017 24
7.1 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the US, Revenue ($bn), Historic, 2003-2010 24
7.2 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the US, Revenue ($bn), Forecast, 2010-2017 25
7.3 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Canada, Revenue ($m), Historic, 2003 - 2010 26
7.4 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Canada, Revenue ($m), Forecast, 2010 - 2017 27
7.5 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the UK, Revenue ($m), Historic, 2003 - 2010 28
7.6 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, the UK, Revenue ($m), Forecast, 2010 - 2017 29
7.7 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Germany, Revenue ($m), Historic, 2003 - 2010 30
7.8 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Germany, Revenue ($m), Forecast, 2010 - 2017 31
7.9 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, France, Revenue ($m), Historic, 2003 - 2010 32
7.10 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, France, Revenue ($m), Forecast, 2010 - 2017 33
7.11 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Italy, Revenue ($m), Historic, 2003 - 2010 34
7.12 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Italy, Revenue ($m), Forecast, 2010-2017 35
7.13 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Spain, Revenue ($m), Historic, 2003 - 2010 36
7.14 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Spain, Revenue ($m), Forecast, 2010 - 2017 37
7.15 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Japan, Revenue ($m), Historic, 2003 - 2010 38
7.16 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Japan, Revenue ($m), Forecast, 2010 - 2017 39
7.17 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, China, Revenue ($m), Historic, 2003 - 2010 40
7.18 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, China, Revenue ($m), Forecast, 2010-2017 41
7.19 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, India, Revenue ($m), Historic, 2003 - 2010 42
7.20 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, India, Revenue ($m), Forecast, 2010 - 2017 43
7.21 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Australia, Revenue ($m), Historic, 2003 - 2010 44
7.22 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Australia, Revenue ($m), Forecast, 2010 - 2017 45
7.23 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillator Market, Brazil, Revenue ($m), Historic, 2003 - 2010 46
7.24 Implantable Cardioverter Defibrillators and Cardioverter Resynchronization Therapy Defibrillators Market, Brazil, Revenue ($m), Forecast, 2010 - 2017 47
8 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators Market - Strategic Competitive Assessment 48
8.1 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators, Global, Company Share (%), 2010 48
8.2 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators, Opportunities and Threats 49
8.2.1 Opportunities 49
8.2.2 Threats 49
8.3 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators, Key Market Participants 50
8.3.1 Medtronic, Inc 50
8.3.2 St Jude Medical, Inc 51
8.3.3 Boston Scientific Corporation 52
8.3.4 Biotronik 53
8.3.5 Sorin Group 54
9 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Key Marketed Products 55
9.1 Protecta XT DR/VR and Protecta DR/VR ICDs 55
9.1.1 Product Description 55
9.1.2 Features and Benefits 55
9.2 Secura DR/VR ICDs 55
9.2.1 Product Description 55
9.2.2 Features and Benefits 55
9.3 Protecta XT and Protecta CRT-Ds 55
9.3.1 Product Description 55
9.3.2 Features and Benefits 55
9.4 Consulta CRT-Ds 56
9.4.1 Product Description 56
9.4.2 Features and Benefits 56
9.5 Maximo II CRT-Ds 56
9.5.1 Product Description 56
9.6 AnalyST Accel ICDs 56
9.6.1 Product Description 56
9.6.2 Features and Benefits 56
9.7 Atlas and Atlas II ICDs 57
9.7.1 Product Description 57
9.7.2 Features and Benefits 57
9.8 Current Accel DR/VR ICDs 57
9.8.1 Product Description 57
9.8.2 Features and Benefits 57
9.9 Current RF ICDs 57
9.9.1 Product Description 57
9.9.2 Features and Benefits 57
9.10 Epic and Epic II ICDs 58
9.10.1 Product Description 58
9.10.2 Features and Benefits 58
9.11 Epic HF CRT-Ds 58
9.11.1 Product Description 58
9.11.2 Features and Benefits 58
9.12 Fortify and Fortify ST ICDs 58
9.12.1 Product Description 58
9.12.2 Features and Benefits 58
9.13 PROMOTE CRT-Ds 59
9.13.1 Product Description 59
9.13.2 Features and Benefits 59
9.14 TELIGEN ICDs 59
9.14.1 Product Description 59
9.14.2 Features and Benefits 59
9.15 CONFIENT ICDs 60
9.15.1 Product Description 60
9.15.2 Features and Benefits 60
9.16 VITALITY ICDs 60
9.16.1 Product Description 60
9.17 COGNIS CRT-Ds 60
9.17.1 Product Description 60
9.17.2 Features and Benefits 60
9.18 CONTAK RENEWAL Series CRT-Ds 61
9.18.1 Product Description 61
9.18.2 Features and Benefits 61
9.19 LIVIAN CRT-Ds 61
9.19.1 Product Description 61
9.19.2 Features and Benefits 61
9.20 Lumax 540 series ICDs and CRT-Ds 62
9.20.1 Product Description 62
9.20.2 Features and Benefits 62
9.21 Lumax 300/340 VR-T (XL)/DR-T ICD and CRT-Ds 62
9.21.1 Product Description 62
9.21.2 Features and Benefits 62
9.22 Ovatio CRT-D 62
9.22.1 Product Description 62
9.22.2 Features and Benefits 62
9.23 Paradym Family of ICDs 63
9.23.1 Product Description 63
9.23.2 Features and Benefits 63
9.24 Paradym CRT-D 63
9.24.1 Product Description 63
9.24.2 Features and Benefits 63
10 Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Pipeline Assessment 64
10.1 Implantable Cardioverter Defibrillators, Pipeline Products 64
10.1.1 AnalyST ACCEL ICD 65
10.1.2 AnalyST ICD 65
10.1.3 CardiaLen ICD 66
10.1.4 Chronicle ICD 66
10.1.5 Current Plus ICD 68
10.1.6 ENERGEN ICD 69
10.1.7 FORTIFY ST ICD 69
10.1.8 INCEPTA ICD 70
10.1.9 Paradym DR ICD 70
10.1.10 Paradym VR Model 8250 ICD 71
10.1.11 PUNCTUA ICD 71
10.1.12 S-ICD 72
10.1.13 Unconditional MRI Compatible ICD 73
10.2 Cardiac Resynchronization Therapy-Defibrillators, Pipeline Products 74
10.2.1 ENERGEN CRT-D 75
10.2.2 INCEPTA CRT-D 75
10.2.3 Next Generation Quad Polar CRT- D 76
10.2.4 Paradym RF 8770 SonR CRT-D 76
10.2.5 Clinical Trials 77
10.2.6 Paradym RF CRT-D 77
10.2.7 Platinium ICD - CRT-D 78
10.2.8 Promote Quadra CRT- D 78
10.2.9 PUNCTUA CRT-D 80
10.2.10 Unify Quadra CRT-D 80
11 Implantable Cardioverter Defibrillators and CardiacResynchronization Therapy Defibrillator Market - Deals Landscape 81
11.1 Boston Scientific Corporation Completes Acquisition of Atritech 81
11.2 Boston Scientific Corporation Enters into an Agreement with Fukuda Denshi 81
11.3 St. Jude Medical Enters into an Agreement with iRhythm Technologies 82
11.4 CLT Forms Joint Venture Company with Erasmus 82
11.5 AorTech International Expands Licensing Agreement with St. Jude Medical 82
12 Appendix 83
12.1 Definitions 84
12.1.1 Cardiac Resynchronization Therapy - Defibrillator 84
12.1.2 Implantable Cardioverter Defibrillator 84
12.1.3 Dual Chamber Implantable Cardioverter Defibrillator 84
12.1.4 Single Chamber Implantable Cardioverter Defibrillator 84
12.2 Acronyms 84
12.3 Research Methodology 86
12.4 Secondary Research 87
12.5 Primary Research 87
12.6 Models 87
12.7 Forecasts 88
12.8 Expert Panels 88
12.9 GlobalData Consulting 88
12.10 Contact Us 88
12.11 Disclaimer 88
12.12 Sources 89